OTC Dry Eye Drops Market (2026 - 2033)

OTC Dry Eye Drops Market Summary

The global OTC dry eye drops market size was valued at USD 4.3 billion in 2025 and is projected to grow from USD 4.6 billion in 2026 to USD 7.2 billion by 2033, at a CAGR of 6.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 40.0% in 2025. The market is experiencing growth driven by factors such as the rising prevalence of dry eye syndrome, changing lifestyles, greater awareness of eye health, and an increase in cases of irreversible, vision-threatening disorders.

Moreover, the growing geriatric population is expected to further drive market growth. In 2025, a study published in the National Center for Biotechnology Information (NCBI) revealed that the prevalence of dry eye disease was approximately 33.7% among individuals aged 60 and older. This statistic highlights the significant burden of the condition within the geriatric population. The increasing prevalence of dry eye disease in older adults, coupled with the rising use of digital devices that can strain the eyes and contribute to dryness, is expected to drive demand for related products.

Another factor contributing to market growth is the rising use of contact lenses. Contact lens-associated dry eye syndrome is becoming a significant public health concern. According to an article in Dove Medical Press, about 140 billion people worldwide wear contact lenses. However, approximately 10-50% of these individuals discontinue use within three years. One of the main reasons for discontinuation is dry eye. Studies show that around 40% of soft contact lens wearers experience dry eye symptoms, and about 25% report moderate to severe symptoms, which often leads to shorter wear times. All these factors are anticipated to contribute to growth in the OTC dry eye drops industry during the forecast period.

The relatively low cost of these drugs makes them very affordable for a large patient base, especially in low- and middle-income countries. They are commercially available and easily accessible. Some of the most commonly prescribed OTC products include Refresh Plus, Refresh Tears, Refresh Liquigel, GenTeal, Tears Naturale II, Tears Plus, HypoTears, Systane (thick), and Soothe.

Analyst Perspective

The OTC dry eye drops industry is experiencing steady growth, driven by increasing consumer awareness of eye health, rising prevalence of dry eye symptoms, and growing interest in self-care solutions. Consumers are increasingly incorporating OTC dry eye drops into their daily eye care routines due to their benefits, including lubrication, relief of irritation, and improved overall eye comfort. The expanding use of digital devices, aging population, and growing exposure to environmental factors that contribute to dry eye conditions are further supporting market growth. As demand for convenient, effective, and easily accessible eye care products continues to rise, companies that focus on product innovation, formulation enhancements, and application diversification will be well-positioned to capitalize on long-term growth opportunities.

Type Insights

The generics segment led the market with the largest revenue share of over 55.0% in 2025. The high share of this segment is primarily due to the cost-effectiveness of generic products. These are often more affordable than their brand-name counterparts, making generic products a more affordable alternative in markets where consumers are price-sensitive and seeking cost-effective options to manage their conditions. Additionally, ease of purchase further boosts segment growth, as generic products are readily available without a prescription, making them accessible to consumers.

The branded segment is anticipated to register at a lucrative CAGR over the forecast period. Branded products have an established reputation and recognition in the market; therefore, consumers place greater trust in them and choose products from well-known, reputable brands because of their track record of quality and efficacy. Moreover, branded products have unique formulations and delivery methods protected by patents. This exclusivity can give these brands an edge in the market until generics can replicate or improve upon the patented features, thereby contributing to the overall growth.

Product Type Insights

The preservative segment led the market with the largest revenue share of over 60.0% in 2025. Preservative-containing dry eye drops tend to have a longer shelf life than preservative-free alternatives. This longer shelf life can be attractive to both manufacturers and consumers, as it reduces the risk of product expiration and wastage. Furthermore, preservatives prevent bacterial growth in the solution, allowing the product to be stored at room temperature. This storage convenience makes preservative-containing products more desirable to consumers, thereby contributing to overall growth.

The preservative-free segment is expected to experience at the fastest CAGR during the forecast period. Preservative-free eye drops are formulated without chemical preservatives, a significant advantage for individuals who are sensitive to or allergic to these substances. In addition, there is growing awareness of the potential drawbacks of using preservatives in eye drops, including dryness, discomfort, and allergic reactions. As a result, consumers are becoming more aware of the ingredients in the products they use and are actively seeking preservative-free options.

Viscosity Insights

The low-viscosity segment led the market with the largest revenue share of around 75.0% in 2025. Ease of application and rapid relief are the primary factors driving segment growth. Low-viscosity eye drops are often easier to wear due to their thin and watery consistency. This makes them more comfortable to use, especially for individuals who may have difficulty with thicker or more viscous formulations. Moreover, low-viscosity eye drops tend to spread quickly across the ocular surface, providing rapid relief for dry, irritated eyes. In addition, low-viscosity eye drops are better tolerated and easier to use than gel ocular drops or ointments.

The high-viscosity segment is expected to witness at the fastest CAGR during the forecast period. High-viscosity eye drops can provide a longer duration of effect than low-viscosity eye drops; thus, this longer duration is a major factor boosting overall growth. Furthermore, high-viscosity eye drops can reduce friction, which can otherwise lead to inflammation, and minimize vision blurring, thereby improving ocular comfort.

Distribution Channel Insights

The retail pharmacies segment led the market with the largest revenue share of around 40.0% in 2025. Accessibility and convenience play a crucial role in driving segment growth. Retail pharmacies, including chain pharmacies and independent drugstores, are widespread and easily accessible to consumers. They are often conveniently located in neighborhoods, shopping centers, and healthcare facilities, making it easy for consumers to purchase OTC products like dry eye drops. Moreover, retail pharmacies offer one-stop shopping for a wide range of healthcare products, including OTC medications, supplements, personal care items, and more. This convenience encourages consumers to buy more products from retail pharmacies, thereby driving the segment's growth.

The online pharmacies segment is expected to witness at a significant CAGR during the forecast period. Online pharmacies save consumers’ time by eliminating the need to travel to a physical pharmacy. In addition, the growing adoption of digital healthcare platforms, e-prescriptions, and home delivery services is accelerating the use of online pharmacies to purchase OTC healthcare products, including dry eye drops. For instance, in January 2025, Walgreens and DoorDash expanded nationwide on-demand delivery services, enabling consumers to receive health and wellness products, including over-the-counter eye care solutions, directly at their doorstep.

Regional Insights

North America dominated the global OTC dry eye drops market with the largest revenue share of around 40.0% in 2025, driven by its large consumer base, advanced healthcare infrastructure, high health product awareness and education, and an aging population with increased susceptibility to dry eye. Moreover, the significant presence of pharmaceutical companies focusing on OTC products, higher disposable incomes, a supportive regulatory framework, and a strong retail pharmacy network further propel regional growth. According to recent epidemiological analyses and meta-analyses published in 2025, dry eye disease (DED) remains a significant public health burden in the U.S. Current estimates indicate that approximately 8.1% of U.S. adults have dry eye disease, while more than 16 Billion Americans have been formally diagnosed with the condition.

Asia Pacific OTC Dry Eye Drops Market Trends

The OTC dry eye drops market in the Asia Pacific is estimated to grow at the fastest CAGR over the forecast period, driven by its large and burgeoning population, an aging demographic leading to higher dry eye prevalence, and an ever-expanding middle class with increased purchasing power. The market in this region is highly price-sensitive and provides better growth opportunities for generic OTC dry eye drops.

Key OTC Dry Eye Drops Company Insights

Major market players are focused on strategic initiatives, including launches, mergers & acquisitions, and partnerships. Furthermore, several players are focusing on developing testing services, thereby boosting demand for products.

Key OTC Dry Eye Drops Companies.

The following key companies have been profiled for this study on the OTC dry eye drops market:

• Rohto Pharmaceutical Co. Ltd.

• AbbVie, Inc.

• Johnson & Johnson Services Inc.

• Santen Pharmaceutical Co. Ltd.

• Novartis AG

• Prestige Consumer Healthcare Inc.

• Altaire Pharmaceuticals Inc.

• Sentiss Pharma Private Limited

• Medicom Healthcare Ltd.

Recent Developments

• In June 2026, Bausch + Lomb launched Blink Triple Care Preservative Free Lubricant Eye Drops in the U.S. The product utilizes the same clinically proven formula as Blink Triple Care while offering preservative-free, multi-dose delivery and up to 10 hours of dry eye symptom relief. The launch expanded the company’s OTC dry eye portfolio and reflected growing consumer demand for preservative-free eye care solutions.

• In February 2025, Alcon announced the U.S. launch of SYSTANE PRO Preservative-Free, a next-generation OTC dry eye drop featuring a preservative-free triple-action formula designed to hydrate, restore, and protect the ocular surface. The launch expanded the company’s SYSTANE product range and highlighted ongoing innovation in OTC dry eye treatments to improve patient comfort and convenience.

OTC Dry Eye Drops Market Report Scope

Global OTC Dry Eye Drops Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global OTC dry eye drops market report based on type, product type, viscosity, distribution channel, and region:

• Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • Branded

  • Generics

• Product Type Outlook (Revenue, USD Billion, 2021 - 2033)

  • With Preservatives

  • Preservatives Free

• Viscosity Outlook (Revenue, USD Billion, 2021 - 2033)

  • Low Viscosity

  • High Viscosity

• Distribution Channel Outlook (Revenue, USD Billion, 2021 - 2033)

  • Drugstores and Supermarkets

  • Online Pharmacies

  • Retail Pharmacies

  • Others

• Regional Outlook (Revenue, USD Billion, 2021 - 2033)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Mexico

    • Argentina

  • Middle East and Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait